Perioperative myocardial injury increases both the mortality and morbidity of cardiac surgery 1 . Moreover, the late outcome of cardiac surgery is also influenced by perioperative myocardial injury 2 . This complication may occur even in off-pump coronary artery bypass graft surgery (OPCAB) 2, 3 .
In two recent clinical trials 4, 5 , remote ischaemic preconditioning (RIPC) had a myocardial protective effect in patients undergoing cardiac surgery and showed two distinguishing features. First, RIPC could be performed by a simple and safe procedure: brief inflations of a pneumatic tourniquet on the upper or lower limb. Second, the protective effect was very powerful. Although only 37 and 57 patients were recruited in the two previous clinical trials respectively, a significant difference was found with only a single preconditioning induction. Moreover, in the study on the patients undergoing coronary artery bypass graft surgery (CABG), postoperative troponin levels were reduced by nearly half 5 .
However, the effect of RIPC has not been evaluated in patients undergoing OPCAB. Considering the increasing popularity of OPCAB and different myocardial injury between on-and off-pump CABG 6 , a clinical study of RIPC in patients undergoing OPCAB is warranted.
The aim of this study was to determine if RIPC could induce myocardial protection in OPCAB patients. We conducted a randomised controlled clinical trial in which RIPC was induced by upper limb pneumatic cuff inflation. Myocardial injury was evaluated by postoperative serum troponin levels and compared between the RIPC and control groups.
MATERIALS AND METHODS

Patients
After receiving approval from the Institutional Review Board, we enrolled 80 adult patients who 
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In several recent clinical trials on cardiac surgery patients, remote ischaemic preconditioning (RIPC) showed a powerful myocardial protective effect. However, the effect of RIPC has not been studied in patients undergoing off-pump coronary artery bypass graft surgery. We evaluated whether RIPC could induce myocardial protection in off-pump coronary artery bypass graft surgery patients. Patients undergoing elective off-pump coronary artery bypass graft surgery were randomly allocated to the RIPC (n=65) or control group (n=65). After induction of anaesthesia, RIPC was induced by four cycles of five-minute ischaemia and reperfusion on the upper limb using a pneumatic cuff. Anaesthesia was maintained with sevoflurane, remifentanil and vecuronium. Myocardial injury was assessed by troponin I before surgery and 1, 6, 12, 24, 48 and 72 hours after surgery. There were no statistical differences in troponin I levels between RIPC and control groups (P=0.172). Although RIPC reduced the total amount of troponin I (area under the curve of troponin increase) by 26%, it did not reach statistical significance (RIPC group 53.2±72.9 hours.ng/ml vs control group 67.4±97.7 hours.ng/ml, P=0.281).
In this study, RIPC by upper limb ischaemia reduced the postoperative myocardial enzyme elevation in offpump coronary artery bypass graft surgery patients, but this did not reach statistical significance. Further study with a larger number of patients may be needed to fully evaluate the clinical effect of RIPC in off-pump coronary artery bypass graft surgery patients.
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Anaesthesia and Intensive Care, Vol. 38, No. 5, September 2010 were referred for elective OPCAB between December 2008 and May 2009. Informed consent was obtained before enrolment. Patients were randomly allocated to the RIPC or control group by a computer-generated random code. Between November 2009 and February 2010, we enrolled an additional 50 patients and randomised them. Exclusion criteria were age greater than 80 years, unstable angina, preoperative use of inotropic agents or mechanical assist devices, left ventricular ejection fraction less than 30%, major combined operation such as vascular surgery, severe liver, renal or pulmonary disease, recent myocardial infarction (within seven days), recent systemic infection or sepsis (within seven days), preoperative use of nicorandil, peripheral vascular disease or amputation of an upper limb. Antiplatelet therapies other than aspirin were stopped one week before the operation. Aspirin was stopped one day before the operation and started again on the first postoperative day. Oral hypoglycaemic agents such as sulphonylureas were stopped three days before the operation.
An anaesthesia nurse who was not involved in patient treatment performed the patient allocation and RIPC procedure. The surgeons and anaesthesiologists, including the researchers, were blinded to the group assignments.
Remote ischaemic preconditioning protocol
RIPC was induced in the upper arm using a pneumatic blood pressure cuff inflated to 200 mmHg by an automated cuff-inflator. There were four cycles of five-minute ischaemia and fiveminute reperfusion. All the procedures were the same in the control group, except for the fact that the three-way stopcock between the pneumatic cuff and the cuff inflator was opened and therefore the cuff pressure did not increase. RIPC protocol was applied just once after anaesthesia induction, usually during the graft vessel harvesting.
Anaesthetic and surgical procedures
All the patients were treated by a single anaesthesiologist and a single surgeon with the same anaesthetic and surgical techniques. In the operating room, patients received routine monitoring consisting of five-lead electrocardiography with STsegment analysis, radial arterial pressure, pulmonary artery catheter, transoesophageal echocardiography, pulse oximetry, capnography and nasopharyngeal temperature. Anaesthesia was induced with intravenous midazolam (0.15 mg/kg) and sufentanil (1 μg/kg), and maintained with inhaled sevoflurane (1 to 2 minimum alveoloar concentration volume percentage) and intravenous remifentanil (0.8 μg/kg/ minute). Vecuronium was used for muscle relaxation. A pulmonary artery catheter (Swan-Ganz CCOmbo CCO/SvO, Edwards Lifesciences, Irvine, CA, uSA) was inserted via the right internal jugular vein. A transoesophageal echocardiography probe was then placed in the oesophagus. Cardiac index and mean arterial blood pressure were maintained at a minimum of 2.0 l/min/m 2 and 65 mmHg, respectively, using volume loading or vasopressors (mainly nonadrenaline). All patients received heparin to maintain the activated clotting time greater than 300 seconds during the anastomoses. The effect of heparin was reversed with protamine after the anastomoses were completed.
The coronary bypass grafts (internal thoracic artery or saphenous vein grafts) were constructed without cardiopulmonary bypass (CPB). To facilitate the anastomoses with the beating heart, a compression-type mechanical stabiliser (ultima Stabilizer; Guidant, Cupertino, CA, uSA) or suctiontype mechanical stabiliser (Octopus; Medtronic, Minneapolis, MN, uSA) was used. A Blower/ Mister (Visuflo; Baxter Healthcare, Midvale, UT, uSA) using carbon dioxide gas and a microsucker system with a rubber tip were also used to obtain a bloodless surgical field. After surgery, patients were transferred to the intensive care unit on mechanical ventilation.
Blood analysis
The serum concentration of troponin I was measured before surgery and 1, 6, 12, 24, 48 and 72 hours after surgery. Troponin I concentrations were measured quantitatively by a one-step immunoassay based on chemiluminescence technology (uniCel ® DxI 800 Access Immunoassay system; Beckman Coulter, Brea, CA, uSA). Myocardial injury was defined as an increase in troponin I greater than 0.5 ng/ml, and the lower detection concentration of this assay was 0.01 ng/ml.
Statistical analysis
In our pilot study, the area under the curve (AuC) of troponin for the first 72 hours postoperatively was 70±59 hours.ng/ml. Hausenloy and colleagues 5 found a 43% reduction of the AuC by RIPC. A sample size of at least 124 patients was needed to detect a 30.1 hours.ng/ml difference in AuC with a power of 0.8 and significance at the two-sided 5% level. A standard trapezoidal method was used to determine the AuC of the troponin I concentration Troponin I levels between the two groups were compared using analysis of variance techniques for repeated measurements with Bonferroni correction. Patient characteristics were assessed by the unpaired t-test or rank sum test (if not normally distributed). Categorical data were compared with chi-square or Fisher's exact test where appropriate. All results were expressed as mean ± SD, and P <0.05 was considered to be statistically significant. Statistical analysis was performed with the SigmaStat ver.3.10 (Systat Software, Inc., Chicago, IL, uSA) and the SPSS Statistics ver.17.0 (SPSS Inc., Chicago, IL, uSA) for Windows.
RESuLTS
Of the 147 patients who were assessed for eligibility ( Figure 1) , 130 patients finished the study (65 in the RIPC group, 65 in the control group). The baseline characteristics were comparable between the two groups ( Table 1 ). There were no major complications (death, myocardial infarction, stroke) during surgery or during the postoperative course. Mechanical ventilation time, intensive care unit stay and hospital stay were not different ( Table  2 ). The time intervals between the end of RIPC and coronary artery clamping were 19.2±10.8 minutes in the RIPC group and 18.5±8.0 minutes in the control group (P=0.990). There were no adverse effects related to the RIPC procedure.
Baseline concentrations of troponin I before surgery were less than 0.5 ng/ml in all patients (RIPC 0.05±0.07 ng/ml vs control 0.04±0.03 ng/ml, P=0.105). After surgery, troponin I levels were increased significantly in both groups (P <0.001), and peak values were reached approximately six hours after the end of surgery ( Figure 2 ). However, there was no significant difference in troponin I level between the RIPC and control group (P=0.172). Table 3 displays troponin levels at each time point. Although the mean values of troponin I were consistently lower in the RIPC group, this was not statistically significant. The total AuCs of the postoperative troponin I (0 to 72 hours) were 53.2±72.9 hours.ng/ml in the RIPC group and 67.4±97.7 hours.ng/ml in the control group (P=0.281). Although RIPC reduced the total amount of troponin I increase (AuC) by 26%, it did not reach statistical significance.
DISCuSSION
In this study, RIPC by upper limb ischaemia reduced the total amount of troponin I by 26%. However, this did not reach statistical significance. This finding contrasts with the results of previous studies in which RIPC showed a powerful myocardial protective effect in patients undergoing cardiac surgery 4, 5 .
The use of the off-pump technique may be one reason for this difference. In this study, the operation was performed without CPB, in contrast to the two previous studies. By avoiding CPB, an off-pump technique reduces the inflammatory response 8, 9 and reduces the myocardial ischaemia reperfusion injuries caused by aortic cross-clamping and cardioplegic arrest. Consequently, the postoperative myocardial enzyme increase after OPCAB is less than those after conventional on-pump CABG [10] [11] [12] [13] . Moreover, the myocardial injury during OPCAB may be determined by factors such as collateral circulation of coronary arteries 14 , coronary occluding time 15, 16 and haemodynamic changes during anastomosis 17, 18 . The degree of myocardial injury by these factors may be more variable among the patients compared to that by the aortic cross-clamp and cardioplegic arrest. Consequently, these different mechanisms and degree of myocardial injury during OPCAB might conceal the protective effect of RIPC. This suggests that a larger study may be necessary to fully investigate the myocardial protective effect of RIPC during OPCAB. Different kinds of myocardial enzyme measurement and operations may be another reason for different results. In our study, we measured troponin I levels to evaluate postoperative myocardial injury, while Hausenloy and colleagues 5 measured troponin T levels. However, both troponin I and T are highly sensitive and specific markers of myocardial damage and are recognised as the gold standard for myocardial infarction diagnosis in patients undergoing acute coronary syndromes 19 . Moreover, troponin I and T are equally sensitive and specific and they show similar prognostic significance for acute myocardial infarction 20 . Troponin levels are usually elevated after cardiac surgery, but the degree of elevation varies depending on the nature of the operation 21 . Postoperative troponin levels are higher in patients with valvular or congenital surgery compared to CABG or OPCAB 22 . Moreover, in patients undergoing OPCAB surgery, there are smaller increases of troponin postoperatively than in the on-pump surgery group [11] [12] [13] 22, 23 .
We performed the RIPC procedure just once before the anastomoses period for the protective time window of RIPC to cover the anastomoses period during OPCAB. However, previous studies demonstrated that both the preconditioning and postconditioning have cardioprotective effects 24, 25 . Moreover, de Hert et al 26 showed that the cardioprotective effect of combined preconditioning and postconditioning is more powerful than that by just preconditioning only. Inducing RIPC using the lower limb, with its greater muscle mass, might also augment the RIPC effect.
There are several limitations to this study. First, the number of recruited patients was 80 initially, followed by a further 50 to increase power. In the RIPC group, troponin levels were consistently lower than in the control group and the total amount of troponin release (AuC) was reduced by 26%. However, none of the differences reached statistical significance (P >0.05).
Second, as there is no clinical study about the effect of RIPC in OPCAB, we referred to the study of Hausenloy and colleagues 5 , in which the AuC reduction was 43%. Total myocardial enzyme leakage in OPCAB is significantly less than that in conventional CABG. Therefore, the expected AuC reduction might be smaller. If the reduction of 26% was used for power analysis, more patients (166 patients per group) would be required.
Third, we did not enrol the patients consecutively and this may decrease the statistical accuracy. However, the previous two studies in which RIPC showed the myocardial protection during the cardiac surgeries had even smaller number of patients: 57 and 37 respectively 4, 5 .
In this study, we avoided oral hypoglycaemic agents and nicorandil to prevent the potential effects of these drugs on RIPC. However, sevoflurane was used as the principal anaesthetic agent during the surgery. Sevoflurane has been shown to induce pharmacologic preconditioning effects 27, 28 and the use of inhalational agents has been shown to decrease perioperative troponin elevation during CABG both with 29 and without 30 CPB. Hence, the preconditioning effect caused by inhalational anaesthetic agent may have attenuated the differences in myocardial enzyme levels caused by RIPC in this study. However, in the previous studies in patients undergoing cardiac surgery 4,5 and elective abdominal aortic aneurysm repair 31 , RIPC successfully decreased postoperative myocardial enzyme level, even with inhalational anaesthesia.
In summary, we found that RIPC by upper limb ischaemia reduced the total amount of troponin I (AuC) in patients undergoing OPCAB, but this did not reach statistical significance. Further study with a larger number of patients may be needed to fully evaluate the clinical effect of RIPC in OPCAB patients.
